Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 172,783Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Ryzodeg

02 8Tresiba

03 7Xultophy

PharmaCompass

01

Brand Name : Ryzodeg

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

02

Brand Name : Xultophy

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Xultophy

arrow
BIO Asia-Taiwan
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 398

2019 Revenue in Millions : 359

Growth (%) : 11

blank

03

Brand Name : Tresiba

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Tresiba

arrow
BIO Asia-Taiwan
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 1,459

2019 Revenue in Millions : 1,506

Growth (%) : -3

blank

04

Brand Name : Tresiba

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Tresiba

arrow
BIO Asia-Taiwan
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 1,483

2020 Revenue in Millions : 1,435

Growth (%) : 8

blank

05

Brand Name : Xultophy

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

06

Brand Name : Ryzodeg

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

07

Brand Name : Xultophy

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

08

Brand Name : Ryzodeg

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

09

Brand Name : Tresiba

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Tresiba

arrow
BIO Asia-Taiwan
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2022 Revenue in Millions : 1,364

2021 Revenue in Millions : 1,483

Growth (%) : -8

blank

10

Brand Name : Xultophy

Insulin Degludec

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Xultophy

arrow
BIO Asia-Taiwan
Not Confirmed

Insulin Degludec

Main Therapeutic Indication : Diabetes

Currency : USD

2023 Revenue in Millions : 468

2022 Revenue in Millions : 410

Growth (%) : 15

blank